Clozapine: past, present and future.
作者信息
Correll Christoph U
机构信息
Department of Psychiatry, Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA.
Department of Psychiatry and Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
出版信息
World Psychiatry. 2025 Jun;24(2):153-154. doi: 10.1002/wps.21335.
Abstract
摘要
相似文献
1
Clozapine: past, present and future.
World Psychiatry. 2025 Jun;24(2):153-154. doi: 10.1002/wps.21335.
2
Promoting safer and wider worldwide use of clozapine.
Schizophr Res. 2024 Jun;268:1-6. doi: 10.1016/j.schres.2024.03.003. Epub 2024 Mar 22.
3
Clozapine: past, present, and future.
Lancet Psychiatry. 2024 Jan;11(1):1. doi: 10.1016/S2215-0366(23)00406-6.
4
Associations of the Gut Microbiome With Treatment Resistance in Schizophrenia.
JAMA Psychiatry. 2024 Mar 1;81(3):292-302. doi: 10.1001/jamapsychiatry.2023.5371.
5
An international research agenda for clozapine-resistant schizophrenia.
Lancet Psychiatry. 2023 Aug;10(8):644-652. doi: 10.1016/S2215-0366(23)00109-8. Epub 2023 Jun 14.
6
Factors Associated With Poor Response to Clozapine in Schizophrenia: A Study From Northern India.
J Clin Psychopharmacol. 2022;42(4):345-349. doi: 10.1097/JCP.0000000000001548. Epub 2022 Mar 28.
7
Clinical Predictors of Response to Clozapine in Patients with Treatment Resistant Schizophrenia.
Psychopharmacol Bull. 2011 Sep 15;44(3):51-65.
8
Schizophrenia past clozapine: what works?
J Clin Psychopharmacol. 2013 Feb;33(1):63-8. doi: 10.1097/JCP.0b013e31827a813b.
9
Continuing clozapine with granulocyte colony-stimulating factor in patients with neutropenia.
Ther Adv Psychopharmacol. 2013 Oct;3(5):266-71. doi: 10.1177/2045125313476877.
10
Improved insomnia is one pathway underlying the anti-suicidal properties of clozapine.
Suicide Life Threat Behav. 2024 Dec;54(6):972-981. doi: 10.1111/sltb.13099. Epub 2024 Jun 7.
引用本文的文献
1
Case Report: Third-degree atrioventricular block and respiratory failure caused by clozapine poisoning.
Front Pharmacol. 2025 Jul 18;16:1572578. doi: 10.3389/fphar.2025.1572578. eCollection 2025.
本文引用的文献
1
Comparative effectiveness of antipsychotic treatment strategies for relapse prevention in first-episode schizophrenia in Finland: a population-based cohort study.
Lancet Psychiatry. 2025 Feb;12(2):122-130. doi: 10.1016/S2215-0366(24)00366-3.
2
Efficacy, tolerability, and safety of xanomeline-trospium chloride for schizophrenia: A systematic review and meta-analysis.
Eur Neuropsychopharmacol. 2025 Mar;92:62-73. doi: 10.1016/j.euroneuro.2024.11.013. Epub 2024 Dec 25.
3
Treatment resistance in schizophrenia: a meta-analysis of prevalence and correlates.
Braz J Psychiatry. 2023 Sep-Oct;45(5):448-458. doi: 10.47626/1516-4446-2023-3126. Epub 2023 Sep 17.
4
An international research agenda for clozapine-resistant schizophrenia.
Lancet Psychiatry. 2023 Aug;10(8):644-652. doi: 10.1016/S2215-0366(23)00109-8. Epub 2023 Jun 14.
5
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels.
Pharmacopsychiatry. 2022 Mar;55(2):73-86. doi: 10.1055/a-1625-6388. Epub 2021 Dec 15.
6
Efficacy and safety of clozapine in psychotic disorders-a systematic quantitative meta-review.
Transl Psychiatry. 2021 Sep 22;11(1):487. doi: 10.1038/s41398-021-01613-2.
7
Antipsychotics Use Is Associated With Greater Adherence to Cardiometabolic Medications in Patients With Schizophrenia: Results From a Nationwide, Within-subject Design Study.
Schizophr Bull. 2022 Jan 21;48(1):166-175. doi: 10.1093/schbul/sbab087.
8
International trends in clozapine use: a study in 17 countries.
Acta Psychiatr Scand. 2017 Jul;136(1):37-51. doi: 10.1111/acps.12742. Epub 2017 May 14.
Zotero 插件